1983
DOI: 10.1016/s0140-6736(83)90668-2
|View full text |Cite
|
Sign up to set email alerts
|

Plasmapheresis in Intractable Insulin-Resistant Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1987
1987
2012
2012

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…1,3,4,6 Due to the severity of fl uctuating glucose levels, a trial of therapeutic plasmapheresis was initiated with the goal of achieving improved glycemic control. In addition, after testing normal for TMPT enzyme activity, treatment with azathioprine 50 mg daily was initiated with the goal of augmenting the decreased production of antibodies to insulin.…”
Section: Discussionmentioning
confidence: 99%
“…1,3,4,6 Due to the severity of fl uctuating glucose levels, a trial of therapeutic plasmapheresis was initiated with the goal of achieving improved glycemic control. In addition, after testing normal for TMPT enzyme activity, treatment with azathioprine 50 mg daily was initiated with the goal of augmenting the decreased production of antibodies to insulin.…”
Section: Discussionmentioning
confidence: 99%
“…These range from the insertion and reinsertion of Hickman catheters for intravenous insulin delivery69 to plasmaphoresis to remove an unknown brittle dia-betes-inducing substance. 70 In our experience, invasive procedures are frequently misused and result in unacceptable patient morbidity. These procedures are usually employed in patients in whom an etiology for the brittle diabetes has not been identified (usually because of inadequate clinical testing).…”
Section: Invasive Proceduresmentioning
confidence: 99%